0001357019-14-000002.txt : 20140407 0001357019-14-000002.hdr.sgml : 20140407 20140407130823 ACCESSION NUMBER: 0001357019-14-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140407 DATE AS OF CHANGE: 20140407 EFFECTIVENESS DATE: 20140407 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PLUROGEN THERAPEUTICS INC CENTRAL INDEX KEY: 0001357019 IRS NUMBER: 203893334 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-215029 FILM NUMBER: 14748100 BUSINESS ADDRESS: STREET 1: 2495 GENERAL ARMISTEAD AVENUE CITY: NORRISTOWN STATE: PA ZIP: 19403 BUSINESS PHONE: 6105393670 MAIL ADDRESS: STREET 1: 2495 GENERAL ARMISTEAD AVENUE CITY: NORRISTOWN STATE: PA ZIP: 19403 D 1 primary_doc.xml X0707 D LIVE 0001357019 PLUROGEN THERAPEUTICS INC 2495 GENERAL ARMISTEAD AVENUE NORRISTOWN PA PENNSYLVANIA 19403 6105393670 DELAWARE Plurogen Therapeutics, LLC None Corporation true Neal G Koller 3724A Thomas Point Road Annapolis MD MARYLAND 21403 Executive Officer Director George T. Rodeheaver 845 Carlins Way Charlottesville VA VIRGINIA 22903 Executive Officer Director Adam J. Katz 3131 SW 98 Drive Gainesville FL FLORIDA 32608 Executive Officer Director James B. Farinholt Westham Green #7 300 North Ridge Road Richmond VA VIRGINIA 23229 Director Daniel Brody 503 Faulconer Drive Charlottesville VA VIRGINIA 22903 Director Biotechnology Decline to Disclose 06b false 2014-04-04 false true false 5000 3500000 153194 3346806 An initial closing will occur when issuer has raised $750,000 if raised by April 18, 2014, or such later date as determined by issuer's board of directors. The minimum investment of $5,000 may be waived at the discretion of issuer's board of directors. false 3 0 0 200000 true false PLUROGEN THERAPEUTICS INC /Neal G. Koller/ Neal G. Koller President & CEO 2014-04-04